Trivitron Healthcare a medical technology company, together with the Investment Funds for Health in Africa (IFHA), a leading private equity investor in the healthcare sector in Africa, has now launched the Trivitron Healthcare Africa B.V. (THA), a new medical technology company focused on the African continent.

THA will provide high-quality medical devices and instruments with reliable after-sales service support across Africa, thereby improving access and affordability of medical equipment across the continent.

In its first phase of operations, Trivitron Healthcare Africa will be headquartered in Dubai, United Arab Emirates, with a direct presence and sales and service infrastructure in four major hubs: Nairobi, Kenya; Johannesburg, South Africa; Lagos, Nigeria and Algiers, Algeria.  The company will leverage these hubs to support neighbouring countries and manage an extensive channel partner network across the African continent.

THA’s initial offering will include a complete range of products and after-sales service support in laboratory medicine, medical imaging, critical care, operating room and renal care.  The company will not only distribute and support products manufactured by Trivitron at their  nine USFDA, CE certified factories in India, Finland and Turkey; but it will also distribute and support products from other leading multinational corporations.

In addition, THA will have an exclusive projects division capable of executing turnkey hospital projects in the African continent.  It is already working with a leading healthcare group in East Africa to support the design and equipping of its new flagship hospital in Nairobi, Kenya.  The company will also have a Multi-Vendor Biomedical Engineering Services division to ensure support for healthcare providers across Africa, and focus on academic initiatives, offering paramedical and super specialty support courses in association with reputed academic institutions from India and Europe.

Moreover, THA is in advanced discussions with the International Finance Corporation, a member of the World Bank Group and investor in many of the leading healthcare providers in sub-Saharan Africa, for a debt investment to support its growth strategy.

Dr. GSK Velu, Chairman and Managing Director of Trivitron said that this is a first-of-its-kind venture between the leading medical technology company in India and a leading healthcare private equity investor in Africa, with support from IFC.

“We have  seen an opportunity to improve access to quality healthcare services by creating a provider of high-quality, affordable medical equipment and services.  We are  excited to partner with Trivitron and IFC to turn this vision into a reality.” said Max Coppoolse, Managing Partner, IFHA.